Ropes & Gray ranked second in Bloomberg Global Legal Advisers League Table for 2020 in U.S. equity initial public offerings (underwriter) by both deal volume and deal count totaling $17.4 billion.
The firm ranked third in U.S. equity offerings (underwriter), and also fourth in global equity linked & rights offerings by deal volume, and in the top ten by deal count.
We advised issuers, underwriters and private equity sponsors on numerous significant initial public offerings including Pershing Square Tontine Holdings (the largest U.S. IPO of 2020 and largest SPAC IPO ever), McAfee, nCino, Inc., Beam Therapeutics, Sigilon Therapeutics, Dragoneer Growth Opportunities Corp., Altimeter Growth Corporation, Relay Therapeutics and many others.
In addition, noteworthy Ropes & Gray-advised equity offerings in 2020 included a $6.7 billion secondary offering for Regeneron Pharmaceuticals, a $200 million PIPE investment for Novavax and follow-on offerings for Moderna, Avantor, Elanco, Eversource Energy, Acceleron Pharma, Vapotherm, BRP Inc., and Osmotica Pharmaceuticals, among others.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.